Latest filing published 10 Aug 2026 for Aptevo Therapeutics Inc..
Insider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Dirk Huebner: trading record in brief
Dirk Huebner discloses dealings in Aptevo Therapeutics Inc. to SEC (Form 4). Altogether 2 filings, all relating to 6 August 2026.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 10 August 2026: an option exercise, in Aptevo Therapeutics Inc. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dirk Huebner
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 638 sharesCommon StockSEC:0001193125-26-343073:0
- 156 shares@ US$4.07Common StockSEC:0001193125-26-343073:1
2 of 2 declarations